Literature DB >> 16142349

Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.

Jana Smardová1, Sárka Pavlová, Miluska Svitáková, Diana Grochová, Barbora Ravcuková.   

Abstract

p53 tumor suppressor is a sequence-specific DNA-binding protein that controls the expression of many genes in response to diverse stress stimuli. p53 gene is often mutated in human cancer and in cancer cell lines. Several methods are available for identification of p53 mutations, including functional analysis of separated alleles in yeast (FASAY). FASAY distinguishes yeast colonies expressing functional p53 protein from colonies producing a dysfunctional p53 protein simply on the basis of color. We analyzed the p53 status of 26 human cell lines of different tissue origin using the functional assay in yeast. Wild-type p53 was found in six cell lines and various p53 aberrations in the remaining twenty. FASAY detected temperature-sensitive p53 mutations in breast cancer cell line, BT474, and leiomyosarcoma cell line, SK-LMS-1, and two independent p53 point mutations in SK-UT-1 and SK-LMS-1 leiomyosarcoma cell lines. In addition, the assay revealed that a recombination occurred between the two mutated p53 alleles producing a stable ratio of p53 wild-type alleles (11.7 or 2.7% respectively). In the case of acute myeloid leukemia cell line, ML-1, we detected both wild-type and heterozygous p53 status, depending on the source of the cell line. In Hs913T, HL60 and Saos-2 cell lines, FASAY failed to assess p53 status due to a large deletion/rearrangement of the p53 gene. In acute lymphoid leukemia HPB cell line, we disclosed unknown non-sense mutation in codon 124 of the p53 gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142349

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma.

Authors:  Richard Y Zhao; Dong Liang; Ge Li; Christopher W Larrimore; Bernard L Mirkin
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

2.  Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772).

Authors:  P Heffeter; A Popovic-Bijelic; P Saiko; R Dornetshuber; U Jungwirth; N Voevodskaya; D Biglino; M A Jakupec; L Elbling; M Micksche; T Szekeres; B K Keppler; A Gräslund; W Berger
Journal:  Curr Cancer Drug Targets       Date:  2009-08-01       Impact factor: 3.428

Review 3.  Analysis of TP53 mutation status in human cancer cell lines: a reassessment.

Authors:  Bernard Leroy; Luc Girard; Antoinette Hollestelle; John D Minna; Adi F Gazdar; Thierry Soussi
Journal:  Hum Mutat       Date:  2014-05-06       Impact factor: 4.878

4.  Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma.

Authors:  Alexandra Garancher; Hiromichi Suzuki; Svasti Haricharan; Lianne Q Chau; Meher Beigi Masihi; Jessica M Rusert; Paula S Norris; Florent Carrette; Megan M Romero; Sorana A Morrissy; Patryk Skowron; Florence M G Cavalli; Hamza Farooq; Vijay Ramaswamy; Steven J M Jones; Richard A Moore; Andrew J Mungall; Yussanne Ma; Nina Thiessen; Yisu Li; Alaide Morcavallo; Lin Qi; Mari Kogiso; Yuchen Du; Patricia Baxter; Jacob J Henderson; John R Crawford; Michael L Levy; James M Olson; Yoon-Jae Cho; Aniruddha J Deshpande; Xiao-Nan Li; Louis Chesler; Marco A Marra; Harald Wajant; Oren J Becher; Linda M Bradley; Carl F Ware; Michael D Taylor; Robert J Wechsler-Reya
Journal:  Nat Neurosci       Date:  2020-05-18       Impact factor: 24.884

5.  Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cells.

Authors:  Maria Lucibello; Sara Adanti; Ester Antelmi; Dario Dezi; Stefania Ciafrè; Maria Luisa Carcangiu; Manuela Zonfrillo; Giuseppe Nicotera; Lorenzo Sica; Filippo De Braud; Pasquale Pierimarchi
Journal:  Oncotarget       Date:  2015-03-10

6.  Induction of targeted necrosis with HER2-targeted platinum(iv) anticancer prodrugs.

Authors:  Daniel Yuan Qiang Wong; Jun Han Lim; Wee Han Ang
Journal:  Chem Sci       Date:  2015-03-16       Impact factor: 9.825

7.  Camptothecin and khat (Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIPL, Mcl-1, procaspase-8 and mitochondrial function in acute myeloid leukemia cell lines.

Authors:  Therese Bredholt; Elizabeth Ao Dimba; Hanne R Hagland; Line Wergeland; Jørn Skavland; Kjell O Fossan; Karl J Tronstad; Anne C Johannessen; Olav K Vintermyr; Bjørn T Gjertsen
Journal:  Mol Cancer       Date:  2009-11-13       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.